Stay updated with breaking news from Valuating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Contract demonstrates the agency’s continued commitment to evaluating the acquisition of commercial radio frequency data for situational awareness and intelligence ... | April 3, 2023
Company Continues Process of Evaluating Strategic Alternatives to Enhance Shareholder Value ... | March 31, 2023
Intra-Cellular Therapies, Inc. announced positive topline results from Study 403 evaluating lumateperone 42mg as monotherapy in the treatment of major depressive episodes in patients with major... | March 29, 2023
Study 014/015 is a Phase II trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia Full data suggest a new strategy for the management of TRS patients in... | March 28, 2023
Toronto, Ontario--(Newsfile Corp. - March 28, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution